Implementing the National Medicines Verification System (NMVS) and ensuring its functionality and security has proved to be a demanding endeavour where cross functional cooperation at the level of Member States’ teams, their hard work and dedication have become paramount to achieving our mission. The pan-European feature of NMVS has made it mandatory to develop and […]
A new Letter of Announcement is available from EMVO referring to the status of A7 alerts. EMVO LoA
On this special day, EMVO shares the Letter of Announcement below, wishing a warm Happy Birthday to the European Medicines Verification System (EMVS). LoA EMVO – Happy Anniversary EMVS
February 9th, 2021 marks 2 years since the Falsified Medicines Directive has been implemented, 2 years since the European Medicines Verification System became operational! All the stakeholders: medicines manufacturers, MAHs, End-Users, Software Suppliers, Authorities have been instrumental in achieving all the milestones and in contributing to achieving our mission: implementing a functional and secure National […]
Please be informed that on February 22nd, between 21:00 and 22:30 there is a maintenance session scheduled for the National Medicines Verfication System (NMVS).
The latest Letter of Announcement from EMVO highlights the importance of subscribing to EVI (European Medicines Verification System Information) so as to receive all immediate updates on EMVS (European Medicines Verification System). EMVO – LoA
Below you can find the EMVO Letter of Announcement regarding the increase in A7 alerts. LoA EMVO








